Skip to main content
. Author manuscript; available in PMC: 2018 Jul 31.
Published in final edited form as: Nature. 2018 Jan 31;554(7691):189–194. doi: 10.1038/nature25475

Extended Data Table 3.

PET response criteria CT, computed tomography; FDG-PET, 18F-fluorodeoxyglucose positron-emission tomography; SUVmax, maximum standardised uptake value.

Response category Based on sum of SUVmax from 1 to 5 target lesions. Each target lesion with initial SUVmax of >1.5 × normal liver background SUVmax
Complete metabolic response (CMR) • Reduction of SUVmax of all target lesions to less than normal liver background SUVmax (for non-brain lesions) or less than normal brain background SUVmax (for brain lesions)
AND
• The reduction of all other FDG-avid lesions consistent with disease to less than normal liver background SUVmax
Partial metabolic response (PMR) • Sum of SUVmax of all target lesions is decreased by ≥30% compared to baseline sum of SUVmax of all target lesions
AND
• No new lesions
Stable metabolic disease (SMD) Not satisfying the criteria for CMR. PMR. PMD, or NE
Progressive metabolic disease (PMD) • Sum of SUVmax, of all target lesions is Increased by ≥30%
OR
• Appearance of one or more unequivocal new FDG avid lesions
Not evaluable (NE) • Missing FDG-PET series or incomplete anatomy at follow-up timepoint
• A PET/CT scanner change from baseline
• Variation In FDG uptake time ≥15 minutes compared to baseline
• Change in reconstruction algorithm